Comments on “Strategies for reduction in the duration of intravenous drug use: Interest of drug tracers as quality indicators to improve intravenous to oral switch” (Letter)
File version
Accepted Manuscript (AM)
Author(s)
Ahmadvand, Alireza
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
To the editor, We read with interest, the recent study by Corny et al, in which the authors evaluated the changes of intravenous (IV) to oral (PO) conversion practice in a hospital following sequential interventions during a 5‐year period.1 The interventions were mainly focused on IV to PO conversion of acetaminophen and proton‐pump inhibitors (PPIs), and the conversion practice was evaluated assuming the abovementioned medications as “tracers.” The authors concluded that both medications could be considered as tracers of IV/PO switching practices in the hospital, with respect to the observed correlation between IV/PO ratios for acetaminophen and PPIs and ratios for all drugs. We found the topic of the study and its results important; however, there are a few challenges that we thought need more elaboration, specifically about the robustness of the study's methodologies, and the interpretation of its results
Journal Title
Journal of Evaluation in Clinical Practice
Conference Title
Book Title
Edition
Volume
24
Issue
2
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© 2018 John Wiley & Sons Ltd. This is the peer reviewed version of the following article: Comments on “Strategies for reduction in the duration of intravenous drug use: Interest of drug tracers as quality indicators to improve intravenous to oral switch”, Journal of Evaluation in Clinical Practice, 2018, 24 (2), pp. 454-455, which has been published in final form at https://doi.org/10.1111/jep.12853. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving (http://olabout.wiley.com/WileyCDA/Section/id-828039.html)
Item Access Status
Note
Access the data
Related item(s)
Subject
Public Health and Health Services
clinical audit
clinical safety
health care
Persistent link to this record
Citation
Taghizadeh-Ghehi, M; Ahmadvand, A, Comments on “Strategies for reduction in the duration of intravenous drug use: Interest of drug tracers as quality indicators to improve intravenous to oral switch” (Letter), Journal of Evaluation in Clinical Practice, 2018, 24 (2), pp. 454-455